Tumours derived from Langerhans cells (LCs) are divided into two main subgroups, according to the degree of cytological atypia and clinical aggressiveness: LC histiocytosis (LCH) and LC sarcoma (LCS). LCS is a high-grade neoplasm with obviously malignant cytologic features and the Langerhans cell phenotype, which is rare. Here the clinic-pathologic...
Review on t(12;15)(p13;q25), with data on clinics, and the genes involved.
Review on t(1;14)(p35;q32), with data on clinics, and the genes involved.
Review on t(9;14)(p24;q12), with data on clinics, and the genes involved.
Review on systemic EBV positive T-cell lymphoma of childhood, with data on clinical findings, pathology and genetic alterations.
Review on Primary Cutaneous CD8 Aggressive Epidermotropic Cytotoxic T Cell Lymphoma, with data on clinics, and the genes involved.
Review on t(6;10)(q22;q24), with data on the genes involved.
Review on t(6;12)(q15;p13)
Review on congenital/neonatal and infant leukemias, with data on clinics, pathology, and involved genes.
Review on t(6;12)(q22;q24), with data on the genes involved.
